guest ::
| Home > Publications Database > Higher Level of Mismatch in APOEε4 Carriers for Amyloid-Beta Peptide Alzheimer's Disease Biomarkers in Cerebrospinal Fluid. > print |
| Home > Publications Database > Higher Level of Mismatch in APOEε4 Carriers for Amyloid-Beta Peptide Alzheimer's Disease Biomarkers in Cerebrospinal Fluid. > print |
| 001 | 140732 | ||
| 005 | 20240430120011.0 | ||
| 024 | 7 | _ | |a 10.1177/1759091419845524 |2 doi |
| 024 | 7 | _ | |a pmid:31104469 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC6535906 |2 pmc |
| 024 | 7 | _ | |a altmetric:60862057 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-07054 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Vogelgsang, Jonathan |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
| 245 | _ | _ | |a Higher Level of Mismatch in APOEε4 Carriers for Amyloid-Beta Peptide Alzheimer's Disease Biomarkers in Cerebrospinal Fluid. |
| 260 | _ | _ | |a London |c 2019 |b Sage Publishing |
| 264 | _ | 1 | |3 online |2 Crossref |b SAGE Publications |c 2019-05-19 |
| 264 | _ | 1 | |3 print |2 Crossref |b SAGE Publications |c 2019-01-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1714465337_8224 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Cerebrospinal fluid (CSF) biomarkers are widely used in the diagnosis of dementia. Even though there is a causal correlation between apolipoprotein E ( APOE) genotype and amyloid-beta (Aβ), the determination of APOE is currently not supported by national or international guidelines. We compared parallel measured CSF biomarkers of two independent laboratories from 126 patients who underwent clinical dementia diagnostics regarding the APOE genotype. APOE ε4 reduces Aβ1-42 (Aβ42) and Aβ42 to Aβ 1-40 ratio (Aβ42/40) but not total Tau or phospho-181 Tau CSF levels. Higher discordance rates were observed for Aβ42 and subsequently for Aβ42/40 in APOE ε4 carriers compared with noncarriers, and the correlation between the two laboratories was significantly lower for Aβ42 in APOE ε4 positive patients compared with patients without APOE ε4. These observations demonstrate that the evaluation of CSF Aβ biomarkers needs to be interpreted carefully in the clinical context. Different immunoassays, disparate cutoff values, and APOE should be respected. |
| 536 | _ | _ | |a 342 - Disease Mechanisms and Model Systems (POF3-342) |0 G:(DE-HGF)POF3-342 |c POF3-342 |f POF III |x 0 |
| 542 | _ | _ | |i 2019-01-01 |2 Crossref |u http://journals.sagepub.com/page/policies/text-and-data-mining-license |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 2 | |a Aged |2 MeSH |
| 650 | _ | 2 | |a Aged, 80 and over |2 MeSH |
| 650 | _ | 2 | |a Alzheimer Disease: cerebrospinal fluid |2 MeSH |
| 650 | _ | 2 | |a Alzheimer Disease: genetics |2 MeSH |
| 650 | _ | 2 | |a Amyloid beta-Protein Precursor: cerebrospinal fluid |2 MeSH |
| 650 | _ | 2 | |a Apolipoproteins E: genetics |2 MeSH |
| 650 | _ | 2 | |a Biomarkers: cerebrospinal fluid |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Genotype |2 MeSH |
| 650 | _ | 2 | |a Heterozygote |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Middle Aged |2 MeSH |
| 700 | 1 | _ | |a Vukovich, Ruth |b 1 |
| 700 | 1 | _ | |a Wedekind, Dirk |b 2 |
| 700 | 1 | _ | |a Wiltfang, Jens |0 P:(DE-2719)2811317 |b 3 |e Last author |u dzne |
| 773 | 1 | 8 | |a 10.1177/1759091419845524 |b : SAGE Publications, 2019-01-01 |p 175909141984552 |3 journal-article |2 Crossref |t ASN Neuro |v 11 |y 2019 |x 1759-0914 |
| 773 | _ | _ | |a 10.1177/1759091419845524 |g Vol. 11, p. 175909141984552 - |0 PERI:(DE-600)2485467-0 |q 11<175909141984552 - |p 175909141984552 |t ASN NEURO |v 11 |y 2019 |x 1759-0914 |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/140732/files/DZNE-2020-07054.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/140732/files/DZNE-2020-07054.pdf?subformat=pdfa |
| 856 | 7 | _ | |2 Pubmed Central |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535906 |
| 909 | C | O | |o oai:pub.dzne.de:140732 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2811317 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-342 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Disease Mechanisms and Model Systems |x 0 |
| 914 | 1 | _ | |y 2019 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-08 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ASN NEURO : 2021 |d 2022-11-08 |
| 915 | _ | _ | |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0 |0 LIC:(DE-HGF)CCBYNC4 |2 HGFVOC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2021-01-15T16:50:29Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2021-01-15T16:50:29Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-08 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Double blind peer review |d 2021-01-15T16:50:29Z |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b ASN NEURO : 2021 |d 2022-11-08 |
| 915 | _ | _ | |a National-Konsortium |0 StatID:(DE-HGF)0430 |2 StatID |d 2022-11-08 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-08 |
| 920 | 1 | _ | |0 I:(DE-2719)1410006 |k AG Wiltfang |l Molecular biomarkers for predictive diagnostics of neurodegenerative diseases |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1410006 |
| 980 | 1 | _ | |a FullTexts |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1038/nrn2494 |2 Crossref |o 10.1038/nrn2494 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.jneumeth.2009.06.033 |2 Crossref |o 10.1016/j.jneumeth.2009.06.033 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/hmg/dds296 |2 Crossref |o 10.1093/hmg/dds296 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.mcna.2013.01.001 |2 Crossref |o 10.1016/j.mcna.2013.01.001 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/S1474-4422(07)70178-3 |2 Crossref |o 10.1016/S1474-4422(07)70178-3 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.3233/JAD-160865 |2 Crossref |o 10.3233/JAD-160865 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.jalz.2018.01.010 |2 Crossref |o 10.1016/j.jalz.2018.01.010 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.jalz.2018.02.018 |2 Crossref |o 10.1016/j.jalz.2018.02.018 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.jalz.2018.02.009 |2 Crossref |o 10.1016/j.jalz.2018.02.009 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1056/NEJM199802193380804 |2 Crossref |o 10.1056/NEJM199802193380804 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.jalz.2011.03.005 |2 Crossref |o 10.1016/j.jalz.2011.03.005 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/0896-6273(95)90079-9 |2 Crossref |o 10.1016/0896-6273(95)90079-9 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1073/pnas.90.5.1977 |2 Crossref |o 10.1073/pnas.90.5.1977 |
| 999 | C | 5 | |y 1993 |2 Crossref |o Strittmatter W. J. 1993 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1212/01.WNL.0000128091.92139.0F |2 Crossref |o 10.1212/01.WNL.0000128091.92139.0F |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.3233/JAD-170793 |2 Crossref |o 10.3233/JAD-170793 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1186/1750-1326-2-7 |2 Crossref |o 10.1186/1750-1326-2-7 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/0304-3940(92)90444-C |2 Crossref |o 10.1016/0304-3940(92)90444-C |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|